approved glp 1 for weight loss The FDA a new GLP-1 pill called Foundayo (orforglipron) adults with obesity or who are overweight and have weight-related health issues: https://bit.ly/4toaoTl Weight loss medication online -

A common refrain in survey and qualitative data is some variation of "I just stopped thinking about food all day." That phenomenon often called food noise reduction is one of the most consistent subjective effects of the class

Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage

Real-World Impact and Patient Experience Patients report sustained weight loss, reduced hunger, improved mobility, greater confidence, and enhanced energy and mood

At ~1.67 mg/mL, 1 unit 16.7 mcg

#glp1community #glp1 #glp1patches #real #bffr #unpopularopinion Do they work

However, raised homocysteine is associated with damage to the arteries